Statin pharmacogenomics: pursuing biomarkers for predicting clinical outcomes.
about
Lipids, blood pressure and kidney update 2015Economic Evaluation of a Pharmacogenomics Test for Statin-Induced Myopathy in Cardiovascular High-Risk Patients Initiating a Statin.ABCB1 C3435T polymorphism and the lipid-lowering response in hypercholesterolemic patients on statins: a meta-analysisFrequency distribution of polymorphisms of CYP2C19, CYP2C9, VKORC1 and SLCO1B1 genes in the Yakut population
P2860
Statin pharmacogenomics: pursuing biomarkers for predicting clinical outcomes.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Statin pharmacogenomics: pursuing biomarkers for predicting clinical outcomes.
@ast
Statin pharmacogenomics: pursuing biomarkers for predicting clinical outcomes.
@en
type
label
Statin pharmacogenomics: pursuing biomarkers for predicting clinical outcomes.
@ast
Statin pharmacogenomics: pursuing biomarkers for predicting clinical outcomes.
@en
prefLabel
Statin pharmacogenomics: pursuing biomarkers for predicting clinical outcomes.
@ast
Statin pharmacogenomics: pursuing biomarkers for predicting clinical outcomes.
@en
P2093
P2860
P1433
P1476
Statin pharmacogenomics: pursuing biomarkers for predicting clinical outcomes.
@en
P2093
Adam M Suhy
Damiano Baldassarre
Joseph P Kitzmiller
Katherine Hartmann
Philip F Binkley
Saurabh R Pandey
P2860
P577
2013-08-01T00:00:00Z